These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1448433)

  • 1. The effects of N(4-methylphenyl)diphenimide on lipid metabolism of Sprague Dawley rats.
    Hall IH; Wong OT; Simlot R; Reynolds DJ
    Pharm Res; 1992 Oct; 9(10):1324-9. PubMed ID: 1448433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypolipidemic effects of 1-acetyl-4-phenyl-1,2,4-triazolidine-3,5-dione in rodents.
    Hall IH; Simlot R; Day P; Wong OT; ElSourady H; Izydore RA
    Pharm Res; 1993 Aug; 10(8):1206-11. PubMed ID: 8415409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents.
    Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH
    Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2,3-dihydrophthalazine-1,4-dione on Sprague Dawley rats lipid metabolism and serum lipoproteins.
    Hall IH; Wong OT; Reynolds DJ; Oswald CB
    Biomed Biochim Acta; 1988; 47(4-5):423-33. PubMed ID: 3240293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents.
    Hall IH; Wong OT; Murthy AR; Day PA; Calvin J
    Pharmacol Res Commun; 1987 Dec; 19(12):839-58. PubMed ID: 3448609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats.
    Soria A; Bocos C; Herrera E
    J Lipid Res; 2002 Jan; 43(1):74-81. PubMed ID: 11792725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypolipidemic activity of 6-substituted 6,7-dihydro-5H-dibenz[c,e]azepine and the effects of 6,7-dihydro-5H-dibenz[c,e]azepine on lipid metabolism of rodents.
    Hall IH; Murthy AR; Wyrick SD
    J Pharm Sci; 1986 Jun; 75(6):622-6. PubMed ID: 3735111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypolipidemic activity of 1-acyl- and 1,2-diacyl-3,5-pyrazolidinediones.
    Izydore RA; Bernal-Ramirez JA; Okwisa WA; Yarborough LV; Wong OT; Hall IH
    Pharmazie; 1993 Feb; 48(2):111-7. PubMed ID: 8475157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidemic activity of N,N-dimethyl-n-octadecylamine borane in rodents.
    Hall IH; Griffin TS; Docks EL; Brotherton RJ; Futch G
    J Pharm Sci; 1986 Jul; 75(7):706-10. PubMed ID: 3761173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cholesterol-rich diet causes a greater hypercholesterolemic response in pregnant than in nonpregnant rats and does not modify fetal lipoprotein profile.
    Munilla MA; Herrera E
    J Nutr; 1997 Nov; 127(11):2239-45. PubMed ID: 9349853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic effects of Sophora flavescens and its constituents in poloxamer 407-induced hyperlipidemic and cholesterol-fed rats.
    Kim HY; Jeong DM; Jung HJ; Jung YJ; Yokozawa T; Choi JS
    Biol Pharm Bull; 2008 Jan; 31(1):73-8. PubMed ID: 18175945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and lipoprotein lipid responses to four hypolipid drugs.
    Hazzard WR; Wahl PW; Gagne C; Applebaum-Bowden D; Warnick GR; Albers JJ
    Lipids; 1984 Feb; 19(2):73-9. PubMed ID: 6708754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypolipidemic activity of 3-amino-1-(2,3,4-mononitro-, mono-, or dihalophenyl)propan-1-ones in rodents.
    Huang Y; Hall IH
    Arch Pharm (Weinheim); 1996 Jul; 329(7):339-46. PubMed ID: 8764882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factorial experiment to determine influence of fish protein and fish oil on serum and liver lipids in rabbits.
    Bergeron N; Deshaies Y; Jacques H
    Nutrition; 1992; 8(5):354-8. PubMed ID: 1421781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering effect of cordycepin (3'-deoxyadenosine) from Cordyceps militaris on hyperlipidemic hamsters and rats.
    Gao J; Lian ZQ; Zhu P; Zhu HB
    Yao Xue Xue Bao; 2011 Jun; 46(6):669-76. PubMed ID: 21882527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidative and lipid lowering effects of 7,8-dihydroxy-3- (4-methylphenyl) coumarin in hyperlipidemic rats.
    Yuce B; Danis O; Ogan A; Sener G; Bulut M; Yarat A
    Arzneimittelforschung; 2009; 59(3):129-34. PubMed ID: 19402343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.